Davidson Kempner Capital Management LP 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-10 4:37 pm Sale |
2023-05-08 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 55,144 4.530% |
-35,009 (-38.83%) |
Filing |
| 2023-03-10 4:15 pm Sale |
2023-03-08 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 90,154 7.410% |
-13,985 (-13.43%) |
Filing |
| 2023-01-23 4:30 pm Sale |
2023-01-19 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 104,138 8.560% |
-16,027 (-13.34%) |
Filing |
| 2022-06-10 4:15 pm Purchase |
2022-06-02 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 120,165 9.900% |
120,165 (New Position) |
Filing |